(Q42436184)
Statements
Development of a controlled-release anti-parkinsonian nanodelivery system using levodopa as the active agent (English)
Aminu Umar Kura
Samer Hasan Hussein Al Ali
Sharida Fakurazi
Palanisamy Arulselvan
scientific article published on 16 March 2013